|Bid||2.1900 x 2200|
|Ask||2.2000 x 1200|
|Day's Range||2.0000 - 2.2100|
|52 Week Range||1.8900 - 8.4400|
|Beta (5Y Monthly)||4.23|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Organigram Holdings Inc. ("Organigram" or the "Corporation") (TSX: OGI) (NASDAQ: OGI) announced today that each of the eight nominees listed in its management information circular dated January 23, 2020 (the "Circular") was elected as a director of Organigram at the Annual and Special Meeting of Shareholders (the "Meeting") held on February 25, 2020. The vote was conducted by a show of hands. Detailed results of the votes cast by proxy are set out below:
Greg Engel has been the CEO of OrganiGram Holdings Inc. (TSE:OGI) since 2017. First, this article will compare CEO...
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to continue the roll out of its innovative portfolio of recreational adult use cannabis products including vape pens and cannabis-infused chocolate.
Organigram stock is trading 70% below record highs. Despite the pullback, OGI stock has created massive wealth for early investors.
The cannabis industry is full of overvalued companies that could take years to grow into their valuations. Instead, stick to these two stocks that are leaders in the industry and are still trading relatively cheap.
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce products from its premium adult recreational Edison Cannabis Co. brand have been awarded top honours in the consumer-driven Leafly Readers Choice Awards.
TORONTO — Some of the most active companies traded Thursday on the Toronto Stock Exchange:Toronto Stock Exchange (17,484.77, up 69.60 points.)Bombardier Inc. (TSX:BBD.B). Industrials. Down 57 cents, or 31.84 per cent, to $1.22 on 60.3 million shares.Aurora Cannabis Inc. (TSX:ACB). Health care. Up 10 cents, or 3.72 per cent, to $2.79 on 19.2 million shares.Hexo Corp. (TSX:HEXO). Health care. Down 10 cents, or 4.15 per cent, to $2.31 on 7 million shares.Encana Corp. (TSX:ECA). Energy. Up three cents, or 0.54 per cent, to $5.56 on 6.7 million shares.Organigram Holdings Inc. (TSX:OGI). Health care. Up 36 cents, or 8.89 per cent, to $4.41 on 6.7 million shares.Zenabis Global Inc. (TSX:ZENA). Health care. Down 1.5 cents, or 8.57 per cent, to 16 cents on 5.9 million shares. Companies in the news:Bombardier Inc. — The future of Bombardier Inc. is being called into question after the company said it was actively considering alternatives to reduce its staggering debt. After exiting the commercial aircraft business, selling its aerostructures unit and unloading a large tract of land in Toronto, the company said it is working to reduce debt and "solve its capital structure." Bombardier's shares plunged more than 30 per cent to their lowest level in nearly four years following its release which pointed to a possible withdrawal from a partnership with Airbus in the commercial aircraft previously called the C Series.Magna International Inc. (TSX:MG). Up $1.22 or 1.7 per cent to $70.64. Magna International Inc. is scaling back its partnership with Lyft Inc. to co-develop self-driving technology as it focuses research and development spending on more near-term prospects. It was only about two years ago that the Aurora, Ont.,-based auto parts giant struck an ambitious partnership with ride-hailing firm Lyft to develop and manufacture self-driving systems at scale. The partnership was proposed as a way to merge Magna's automotive expertise with Lyft's data-gathering and real-world testing to roll out technology that they said was expected to be market-ready over the "next few years" as self-driving ambitions in the industry grew.Canadian Tire Corp. Ltd. (TSX:CTC.A). Up $1.48 to $144.79. Canadian Tire Corp. Ltd. is promoting Gregory Craig to the job of chief financial officer, replacing Dean McCann, who is retiring. Craig is president of Canadian Tire Financial Services and president and chief executive of Canadian Tire Bank. He takes over the new job on March 2. McCann will continue as a director of Canadian Tire Bank and a trustee of CT REIT. The company also announced that Mahes Wickramasinghe will become president of Canadian Tire Financial Services and president and chief executive of Canadian Tire Bank.Barrick Gold Corp. (TSX:ABX). Up 22 cents to $23.60. Barrick Gold Corp. says its gold production for 2019 is expected to come in near the top end of its guidance, while copper production is forecast to be more than its earlier expectations. The gold miner says preliminary results indicate it produced 5.5 million ounces of gold last year compared with its guidance for between 5.1 million and 5.6 million ounces. Preliminary copper production results indicate it produced a total of 432 million pounds compared with guidance for between 375 million and 430 million pounds. Barrick says preliminary fourth-quarter results show sales of 1.413 million ounces of gold and 91 million pounds of copper, as well as fourth quarter production of 1.439 million ounces of gold and 117 million pounds of copper.This report by The Canadian Press was first published Jan. 16, 2020.The Canadian Press
Organigram stock spiraled upwards after its stellar fiscal first-quarter 2020 results yesterday. Are macro conditions improving for pot stocks?
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce it has secured a supply agreement with Medical Cannabis by Shoppers, the online medical cannabis platform by Shoppers Drug Mart Inc. ("Shoppers").
Shares of Organigram rose nearly 50 per cent in Wednesday’s trading session on the heels of a strong quarterly results driven in large part by pot sales to other licenced producers.
Organigram Holdings Inc. is anticipating that consumers seeking non-smokable cannabis will help to further boost its revenues that more than doubled to $25.2 million in the first quarter.The company based in Moncton, N.B., says revenues were up from $12.4 million a year earlier.Chief executive Greg Engel foresees tremendous opportunities ahead as demand for vapes, chocolates and powdered products accelerates in the coming months."The feedback we're hearing from the retailers is that the consumer that's coming in today, many of them are consumers who have not come into retail stores because they don't want to look for a dried flower product in the past," he said in an interview.That should translate into new revenues as between 40 to 45 per cent of sales should come from these Rec 2.0 products, according to results in U.S. states.The first vape pens were shipped as planned in December while premium cannabis-infused chocolates are to begin sales later in the quarter.Sales of powdered products, to be added to a consumer's beverage of choice, are expected in the second quarter.Engel declined to provide specific dates for the launch of these products but said one large unnamed province has already tripled its order for cannabis-infused chocolates."There's a tremendous amount of opportunities with 2.0 products. It's going to expand the market dramatically."Revenues during the first quarter included $16.7 million of sales to the adult-use recreational market and about $9.5 million to medical markets, partly offset by a $1.1 million provision for product returns and price adjustments.The provision related to two slow-selling products sold to the Ontario Cannabis Store — a lower THC dried flower and THC oils.Organigram's net loss was $863,000 or less than a cent per share, compared with a loss of $29.5 million or 19.5 cents per share in the prior year. That large loss was largely due to non-cash fair value changes to biological assets and inventories.The cannabis producer was expected to lose $3.9 million or three cents per share on $19.6 million in revenues, according to financial markets data firm Refinitiv.Engel said he's pleased with the solid quarterly results and positive adjusted EBITDA, but wouldn't say when it will become profitable."We're at the point where it's a marginal loss but it is in part because the market really has not grown and we expect that to shift."Organigram said last November that its net revenue in the quarter would be higher than the $16.3 million in the fourth quarter due to increased sales to provinces and higher wholesale revenue.The company said the Canadian cannabis market is poised for growth with more retail store openings planned in Ontario and Quebec, two provinces that together account for more than 60 per cent of the country's population.In particular, Ontario is moving to open more retail stores with approvals to be issued in April at an initial rate of about 20 per month.Quebec also plans to double the number of stores and Alberta's network of 375 stores will continue to grow to meet consumer demand.Legalization of edible and derivative products is also expected to significantly expand the legal market although Newfoundland & Labrador, Quebec and Alberta have announced delays or restrictions on the launch of vaporizable products.That increased demand should allow the company to move fairly quickly to "reinvigorate" its expansion plans, Engel added.This report by The Canadian Press was first published Jan. 14, 2020.Companies in this story: (TSX:OGI)Ross Marowits, The Canadian Press
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce its results for the first quarter ended November 30, 2019 ("Q1" or "Q1 2020").
OrganiGram (OGI) is expected to have benefited from its firm focus on building brand equity and ongoing product innovation in the fiscal first quarter.
OrganiGram (OGI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce it has been chosen as one of Atlantic Canada’s Top Employers.
Hunting for a bargain? This group of beaten-down stocks, including Aurora Cannabis (TSX:ACB)(NYSE:ACB), might provide the value you're looking for.
Aphria (TSX:APHA)(NYSE:APHA) will release quarterly results this month, two more Canadian marijuana names have upcoming news this January.
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2020 ended November 30, 2019 on Tuesday, January 14th after market close.